###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
CTLA4 Autoimmunity-Associated Genotype Contributes to Severe Pulmonary Tuberculosis in an African Population
###end article-title 0
###begin p 1
###xml 169 177 <span type="species:ncbi:9606">patients</span>
###xml 195 198 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
Conceived and designed the experiments: SRG CGM RDH. Performed the experiments: SN. Analyzed the data: TT GS SN CGM. Wrote the paper: TT RDH. Involved in recruitment of patients and controls: EB MAC JG IO EOD.
###end p 1
###begin p 2
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 824 839 824 839 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">corrected [cor]</sub>
###xml 850 853 850 853 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 968 973 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 424 427 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 437 445 <span type="species:ncbi:9606">patients</span>
The gene of Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA4), a negative regulator of T lymphocytes, contains a single-nucleotide polymorphism (SNP) at position +6230A->G (ct60A->G), which has been found associated with several autoimmune diseases and appears to reduce T-cell inhibitory activity. In Ghana, West Africa, we compared the frequencies of CTLA4 +6230 A/G and 6 haplotype-tagging SNPs in 2010 smear-positive, HIV-negative patients with pulmonary tuberculosis (TB) and 2346 controls matched for age, gender and ethnicity. We found no difference in allele frequencies between cases and controls. However, +6230A and a distinct CTLA4 haplotype and a diplotype comprising the +6230A allele were significantly less frequent among cases with large opacities in chest radiographs compared to those with small ones (Pcorrected [cor] = 0.002, Pcor = 0.00045, P = 0.0005, respectively). This finding suggests that an increased T-cell activity associated with the CTLA4 +6230G allele contributes to pathology rather than to protection in pulmonary TB.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Teft1">[1]</xref>
###xml 266 269 266 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Lee1">[2]</xref>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Grohmann1">[7]</xref>
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-BourJordan1">[8]</xref>
###xml 382 385 382 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Nasta1">[9]</xref>
Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4) is considered a key negative regulator of T lymphocytes [1]. Being transiently surface expressed and released by activated T cells, it inhibits T-cell functions through a variety of direct and indirect mechanisms [2]-[7]. In addition, CTLA-4 has been found to skew the activity of T-helper (Th) cells towards a Th1 phenotype [8]-[9].
###end p 4
###begin p 5
###xml 284 288 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Ueda1">[10]</xref>
###xml 367 372 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 485 489 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Ueda1">[10]</xref>
###xml 491 495 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Maier1">[11]</xref>
###xml 568 573 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 816 820 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Ueda1">[10]</xref>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 943 949 <span type="species:ncbi:9606">humans</span>
A G-->A nucleotide exchange at position +6230 (also addressed as CT60; according to alternate numbering located at position +6253 relative to the start codon) in the 3'-untranslated region of the human CTLA-4 gene has been found to support protection from several autoimmune diseases [10]. It was associated with an increased concentration of a splice variant of the CTLA4 transcript encoding a soluble form of the molecule, which was assumed to enhance the T-cell inhibitory function [10], [11]. The authors reasoned that the autoimmunity-supporting +6230G allele of CTLA4, which was found in the majority of members of the European study group, may have been the subject of evolutionary selection by providing enhanced cellular immune responses and, thereby, protection against particular intracellular infections [10]. The identification of this polymorphism provided an important tool to study the overall influence of T-cell responses in humans.
###end p 5
###begin p 6
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Flynn1">[12]</xref>
We studied the CTLA4 +6230 polymorphism in pulmonary tuberculosis (TB) for two reasons. First, T cells are regarded of eminent importance in controlling mycobacterial infections [12]. In addition, TB may be relevant in the evolution of the autoimmunity-associated +6230G allele because it is caused by an intracellular infection and, due to its widespread occurrence and high mortality in the past and today, it may be relevant to natural selection.
###end p 6
###begin p 7
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-RamrezSoriano1">[13]</xref>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
Studying an African population, we included in the analysis four single nucleotide polymorphisms (SNP) which recently have been described to characterize the relevant haplotypes of the CTLA4 gene in Africans [13] and, according to the most recent version of the HapMap database () five additional tagging SNPs providing comprehensive and appropriate coverage of the CTLA4 gene.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
Study group
###end title 9
###begin p 10
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Thye1">[14]</xref>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6110</italic>
###xml 6 18 <span type="species:ncbi:9606">participants</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 416 424 <span type="species:ncbi:9606">patients</span>
###xml 595 598 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Study participants were enrolled in Ghana, West Africa, between September 2001 and July 2004. The study group has been described in detail elsewhere [14]. In brief, patients were recruited at the two major teaching hospitals of Accra and Kumasi, and additional hospitals or policlinics in Accra, Kumasi, Obuasi, Agona, Mampong, Agogo, Konongo, Nkawie, Nkawkaw, Atibie, Assin Fosu and Dunkwa. The characterization of patients comprised a documentation of medical histories on standardized questionnaires, two examinations for acid-fast bacilli of non-induced sputum specimens, a determination of HIV serology and confirmation of positive results by an alternative test, culturing and differentiation of mycobacterial isolates by IS6110 fingerprinting and spoligotyping as well as assessment of drug resistances, and a posterior-anterior chest radiography.
###end p 10
###begin p 11
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 175 178 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Included were patients 6 to 60 years of age, with no history of previous TB or anti-mycobacterial treatments, two sputum smears positive for acid-fast bacilli, and a negative HIV serology. Excluded were individuals with incomplete information provided by the questionnaire or evidence for alcoholism, drug addiction or other apparent generalized disease.
###end p 11
###begin p 12
Unrelated personal contacts and neighbours as well as community members were recruited as controls. Inclusion criteria were no history of previous TB or anti-mycobacterial treatments and no evidence for previous TB in chest radiographs. The characterization of controls included a tuberculin skin test (Tuberculin Test PPD Merieux, bioMerieux, Nurtingen, Germany).
###end p 12
###begin p 13
###xml 848 855 848 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t001">Table 1</xref>
Radiographic films were pseudonymized and read by an experienced radiologist (G. S.). Opacities, cavities, nodular lesions, pulmonary shrinkage (loss of lung volume as assessed by hilus dislocation or displacement of fissures), calcifications, and pleural thickening were individually assigned to the upper right, lower right, upper left, and lower left thoracic quadrants and overall assessed quantitatively being rated "0" (no lesion detectable), "1" (mild lesion), "2" (moderate lesion), and "3" (severe lesion). Enlargements of mediastinal lymph nodes, effusions, and miliary lesions were evaluated qualitatively. The evaluation presented here for the reason of simplicity was restricted to the overall scores for opacities and cavities because these are the most common signs of TB reflecting cellular infiltration and necrosis, respectively (Table 1).
###end p 13
###begin title 14
###xml 39 40 39 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt101">1</xref>
Radiographic findings in the case group1.
###end title 14
###begin p 15
###xml 21 29 <span type="species:ncbi:9606">patients</span>
Shown are numbers of patients and, in brackets, percentages of total (n = 1851).
###end p 15
###begin p 16
###xml 498 510 <span type="species:ncbi:9606">participants</span>
###xml 717 729 <span type="species:ncbi:9606">participants</span>
The final study group comprised 2010 cases and 2346 controls comprising 1211 household contacts and 1135 neighbours or community controls. They belonged to the following ethnic groups (cases/all controls/PPD-positive controls/PPD-negative controls): Akan including Ashanti, Fante, Akuapem (63.6%/59.1%/58.2%/74.8%), Ga-Adangbe (14.5%/19.8%/20.6%/7.0%), Ewe (7.1%/9.3%/9.6%/3.9%) and ethnic groups of northern Ghana, including Mole Dagbane, Gurma, Grusi (12.9%/10.4%/10.3%/12.6%). For 1.6% of study participants the ethnicity was not clearly assignable. The percentage of males among cases, all controls, PPD-positive controls and PPD-negative controls was 68.2%/59.2%/60.2%/42.5%, respectively. The mean age of study participants in these groups was 34.1+/-11.6/32.5+/-12.0/32.4+/-11.8/34.1+/-15.3.
###end p 16
###begin p 17
###xml 52 57 <span type="species:ncbi:9606">Human</span>
###xml 216 224 <span type="species:ncbi:9606">Patients</span>
###xml 404 407 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 554 557 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 581 584 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 645 657 <span type="species:ncbi:9606">participants</span>
###xml 674 677 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
The study protocol was approved by the Committee on Human Research, Publications and Ethics, School of Medical Sciences, Kwame Nkrumah University, Kumasi, and the Ethics Committee of the Ghana Health Service, Accra. Patients were treated according to the "Directly Observed Treatment, Short-course" (DOTS) strategy organized by the National Tuberculosis Programme. Blood samples for genetic analyses and HIV testing were taken only after a detailed explanation of the study aims and written or thumb-printed consent for participation provided, including HIV testing. Disclosure of HIV test results was dependent on the documented willingness of participants to be informed. HIV-positive patients were promptly referred to counseling and treatment as provided by the Ghanaian AIDS Control Programme.
###end p 17
###begin title 18
Genetic Analysis
###end title 18
###begin p 19
###xml 118 123 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 556 563 554 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t002">Table 2</xref>
After DNA extraction from whole peripheral blood by a magnetic separation technology (AGOWA(R), Berlin, Germany), the CTLA4 -1765 (rs11571315), -1722 (rs733618), -1661 (rs4553808), -1577 (rs11571316), -1411 (rs16840252), -443 (rs231774), +49 (rs231775), +923 (rs231777) and +6230 (rs3087243) variants were analysed by dynamic allele specific hybridization with fluorescence resonance energy transfer (FRET) in a LightTyper (Roche Diagnostics, Mannheim, Germany). Primer pair and sensor/anchor oligonucleotides for LightTyper-based genotyping are listed in Table 2.
###end p 19
###begin title 20
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt102">1</xref>
Primers and sensor/anchor oligonucleotides used for CTLA4 genotyping1.
###end title 20
###begin p 21
Performed by dynamic allele specific hybridisation with fluorescence resonance energy transfer (FRET) in a LightTyper(c).
###end p 21
###begin p 22
F, forward primer; R, reverse primer.
###end p 22
###begin p 23
S, sensor; A, anch.
###end p 23
###begin title 24
Statistical Analysis
###end title 24
###begin p 25
The STATA 9 software (Stata Corporation, College Station, TX, USA) was used to test for Hardy Weinberg equilibria (HWE) and odds ratios (OR) of genotype frequencies. Multivariate logistic regression analyses were applied to adjust for age, gender and ethnicities when comparing TB cases with all controls, PPD-negative and PPD-positive controls. Multivariate ordinal logistic regression analyses were performed to determine the influences of genetic variants on the severity scores of radiological signs. Calculations included adjustments for age, gender, ethnicity, recruitment centers and duration of cough, the latter because it was found correlated with the radiographic signs. Haplotype frequencies were estimated and compared using the haplo.score module of the haplo.stats package ().
###end p 25
###begin p 26
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
Associations of the distinct disease phenotypes of opacities and cavities with CTLA4 diplotypes comprising the +6230A allele were determined by weighted ordinal logistic regression analyses. Weights in the regression models were the posterior probabilities of each haplotype pair (diplotype) for each individual as estimated by the haplo.score module of the haplo.stats package.
###end p 26
###begin p 27
###xml 313 316 313 316 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 605 607 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
Corrections for multiple testing of single variants were made by multiplication of P values with 7, the number of genetic variants that are not in strong linkage disequilibria with each other, and the two disease phenotypes examined. The final correction factor was, thus, 14 and corrected P values are given as Pcor. To control haplotype analyses for multiple testing, 20,000 permutations were performed for global and haplotype-specific P values. The study sample provided 80% power to identify significant genotypic differences between TB cases and controls at a statistical support level of alpha = 10-4 with an OR of 1.4 and a minor allele frequency of 0.1 applying a multiplicative model.
###end p 27
###begin title 28
Results
###end title 28
###begin p 29
###xml 34 42 <span type="species:ncbi:9606">patients</span>
The study group consisted of 2010 patients with pulmonary TB and 2346 controls group-matched for age, gender and ethnicity. Controls comprised 2219 purified protein derivative (PPD)-positive and 127 PPD-negative individuals
###end p 29
###begin p 30
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 280 285 280 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 419 426 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t003">Table 3</xref>
###xml 94 101 <span type="species:ncbi:9606">patient</span>
###xml 266 278 <span type="species:ncbi:9606">participants</span>
Genotyping of 8 SNPs located in the CTLA4 gene showed allele distributions in HWE in both the patient and control groups. The minor allele frequencies (MAF) of variants was 15-46%, whereby the +6230 (ct60) A and G alleles were found in 19% and 81%, respectively, of participants. CTLA4 -1722 showed a minor deviation from HWE in the control group but as this occurred in one subgroup only it was considered fortuitous (Table 3).
###end p 30
###begin title 31
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt105">1</xref>
Frequencies and distributions of SNPs studied1.
###end title 31
###begin p 32
The chi2 test was applied to test for deviations from Hardy-Weinberg equilibrium.
###end p 32
###begin p 33
Minor allele frequency.
###end p 33
###begin p 34
P value for a deviation from Hardy-Weinberg equilibrium.
###end p 34
###begin p 35
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006307-g001">Figure 1</xref>
The analysis of pairwise linkage disequilibrium (LD) revealed strong LDs between the variants -1577 with +6230 (R2 = 0.94) and -1147 with -1661 (R2 = 0.96) (Figure 1). Due to these LDs, the SNPs at positions -1577 and -1147 could safely be excluded from further analyses as these variants would not add additional information.
###end p 35
###begin title 36
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
Pairwise linkage disequilibrium (r2) based on 9 CTLA4 SNPs using HaploView 4.0 software.
###end title 36
###begin p 37
###xml 153 160 153 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t002">Table 2</xref>
The figure depicts the strong LD of variants -1577/+6230 and of variants -1147/-1661. The positions relative to the ATG start codon of SNPs are given in Table 2.
###end p 37
###begin p 38
###xml 85 92 85 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t004">Table 4</xref>
###xml 416 431 416 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 439 451 439 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. africanum</italic>
###xml 459 467 459 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 669 676 669 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t005">Table 5</xref>
###xml 883 886 883 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 1085 1088 1085 1088 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 1135 1138 1135 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 416 431 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 439 451 <span type="species:ncbi:33894|species:ncbi:316723">M. africanum</span>
###xml 459 467 <span type="species:ncbi:1765">M. bovis</span>
When comparing cases with controls, genotype frequencies were similar in all groups (Table 4) including subgroups of PPD-positive and PPD-negative controls (data not shown). Associations with disease severity were assessed by multivariate ordinal logistic regression based on quantitative estimates of radiographic signs of opacities and cavities. Age, gender, ethnicity, duration of illness, mycobacterial species (M. tuberculosis 69.1%, M. africanum 30.3%, M. bovis 0.6%), and recruitment site were included as potentially relevant co-variates. The stratifications showed that the A/A genotype of +6230 showed a significant association with low scores for opacities (Table 5) and a similar trend for cavities (data not shown). Compared to the most frequent +6230 G/G genotype, the A/A and A/G genotypes had odds ratios (ORs) of 0.39 (AA vs GG, confidence interval [CI] 0.23-0.65, Pcor = 0.005) and 1.06 (AG vs GG, CI 0.85-1.33, ns), respectively. As no difference was found between A/G and G/G and both genotypes showed similar ORs compared to A/A (GG vs AA, OR 2.57, CI 1.53-4.32, Pcor = 0.005 and AG vs AA, OR 2.72, CI 1.60-4.66, Pcor = 0.003), the disease-aggravating influence associated with the G allele appears to be dominant and the disease-mitigating effect associated with A recessive.
###end p 38
###begin title 39
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt108">1</xref>
CTLA4 genotype frequencies in TB cases and controls1.
###end title 39
###begin p 40
Analysed by logistic regression.
###end p 40
###begin p 41
Variations due to assay failures.
###end p 41
###begin p 42
Odds ratio.
###end p 42
###begin p 43
Confidence interval.
###end p 43
###begin title 44
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt112">1</xref>
CTLA4 genotype frequencies in TB cases stratified for the sizes of opacities in chest radiographs1.
###end title 44
###begin p 45
Analysed by ordinal logistic regression.
###end p 45
###begin p 46
Odds ratio.
###end p 46
###begin p 47
Confidence interval.
###end p 47
###begin p 48
Bonferroni-corrected by the factor of 14 for testing 7 SNPs not in strong linkage disequilibria and two disease phenotypes.
###end p 48
###begin p 49
###xml 139 142 139 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 171 174 171 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 256 259 256 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 288 291 288 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cor</sub>
###xml 301 308 301 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t006">Table 6</xref>
###xml 466 473 466 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006307-t007">Table 7</xref>
The haplotype -1765G/-1722A/-1661A/-443A/+49 G/+923C/+6230A was strongly associated with high opacity scores in a recessive model (global Pcor = 0.03; haplotype specific Pcor = 0.0005) and showed the same, albeit weaker, association with cavities (global Pcor = 0.03; haplotype specific Pcor = 0.03) (Table 6). The same applied to the diplotype containing homozygously this haplotype (opacities: haplotype specific P = 0.0005; cavities: haplotype specific P = 0.05; Table 7).
###end p 49
###begin title 50
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt116">1</xref>
CTLA4 haplotype frequencies in TB cases stratified for the sizes of opacities and cavities in chest radiographs1.
###end title 50
###begin p 51
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
Seven tagging SNPs reported to appropriately indicate CTLA4 haplotypes in sub-Saharan Africans (Ref. 13) analysed by the Haplo.score software assuming a recessive mode of inheritance.
###end p 51
###begin p 52
P values obtained testing an overall association between haplotypes and the phenotype.
###end p 52
###begin p 53
Global P values corrected for multiple testing by 20,000 permutations.
###end p 53
###begin p 54
Frequency; only haplotypes with a frequency>0.01 are shown.
###end p 54
###begin p 55
P values of haplotype-specific associations.
###end p 55
###begin p 56
Simulated haplotype-specific P values corrected for multiple testing by 20,000 permutations.
###end p 56
###begin p 57
Score statistic of the haplo.score software.
###end p 57
###begin title 58
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
CTLA4 diplotype analysis in TB cases stratified for the sizes of opacities and cavities in chest radiographs.
###end title 58
###begin p 59
Odds ratios (OR).
###end p 59
###begin p 60
95% confidence intervals (CI) for the weighted ordinal logistic regression model with weights being the posterior probabilities for each diplotype for each individual.
###end p 60
###begin p 61
Other, haplotype not comprising the +6230A allele.
###end p 61
###begin p 62
HAPct60, haplotype comprising the +6230A allele (-1765 G/-1722 A/-1661 A/-443 A/+49 G/+923 C/+6230 A).
###end p 62
###begin p 63
P values given for haplotype-specific associations.
###end p 63
###begin title 64
Discussion
###end title 64
###begin p 65
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 653 658 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 725 751 725 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 725 751 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Our findings do not provide evidence for a role of the +6230 polymorphism of human CTLA4 in protection against pulmonary TB. On the other hand, our study design was sufficiently sensitive to detect a significant influence of the +6230 variant on the more detailed phenotypes of disease severity as radiograpically assessed by the extent of opacities and size and numbers of pulmonary cavities. The +6230 A/A genotype, which had been found negatively associated with autoimmune disease, was found to also be negatively associated with severe pathology in pulmonary TB. This applied to the major forms of pathology as identified by chest X ray. Thus, the CTLA4 +6230 polymorphism was found to influence pulmonary TB only after Mycobacterium tuberculosis had overcome innate and adaptive host defence mechanisms.
###end p 65
###begin p 66
###xml 124 143 124 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 254 258 254 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Kirman1">[15]</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Quinn1">[16]</xref>
###xml 811 815 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Kirman1">[15]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Lee2">[17]</xref>
###xml 1117 1124 1117 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-situ</italic>
###xml 1514 1518 1514 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Lawn1">[18]</xref>
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 124 143 <span type="species:ncbi:1765">Mycobacterium bovis</span>
###xml 144 168 <span type="species:ncbi:33892">bacillus Calmette-Guerin</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
###xml 875 880 <span type="species:ncbi:9606">human</span>
###xml 1003 1009 <span type="species:ncbi:9606">humans</span>
###xml 1470 1478 <span type="species:ncbi:9606">patients</span>
Our data are partly supported by earlier studies in a murine model of TB. Using experimental aerosol infection of mice with Mycobacterium bovis bacillus Calmette-Guerin (BCG), it was shown that inhibition of CTLA-4 by antibody did not enhance protection [15]. Furthermore, in the same model, depletion of regulatory T cells, which express CTLA-4 constitutively, did not affect protection either [16]. However, the mouse model did not support a role of CTLA-4 in enhancing pathology. Although antibody mediated inhibition of CTLA-4 caused a rise in the number of T cells in lung-draining lymph nodes and an increase in the T-cell proliferative response to mycobacterial antigen, it did not result in increased lymphoid infiltration or granuloma formation in the lung assessed by careful histological examination [15]. As the radiological findings of opacities and cavities in human TB are considered to result from cellular infiltration and necrosis, respectively [17], our observations suggest that, in humans, a reduced activity of CTLA-4 causes an increased cellular infiltration of the lung, which may result from in-situ T-cell proliferation and recruitment of other cell types through cytokines. This is in agreement with the concept that pathology of TB to some extent is immune mediated, which has recently been confirmed by finding a clinical aggravation of pre-existing TB in the course of the immune reconstitution inflammatory syndrome (IRIS) seen among AIDS patients undergoing anti-retroviral therapy [18].
###end p 66
###begin p 67
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 130 136 130 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4A</italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Thio1">[19]</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006307-Kavvoura1">[20]</xref>
###xml 205 211 <span type="species:ncbi:9606">humans</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
Collectively, the observation of the role of the CTLA4 -6230 polymorphism and the occurrence of a haplotype/diplotype bearing the CTLA4A variant in pulmonary TB indicates that a reduced CTLA-4 activity in humans does not enhance protection against pulmonary TB but enhances pathology if containment of the infection fails. Accordingly, pulmonary TB appears not to belong to those infections which may contribute to explain the high prevalence of CTLA4 +6230G in human populations. This evolutionary role may rather be with viral infections including hepatitis B, which was found to be controlled more effectively by carriers of the CTLA4 +6230G allele than by those carrying the +6230A/A genotype [19]. In that study, the +6230G allele appeared to act in a dominant fashion, which is in agreement with the results obtained in autoimmunity [20] but at variance with our data on the severity of TB. An explanation has to await further functional studies.
###end p 67
###begin p 68
The higher frequency of +6230G allele in the Ghanaian study group (>80%) compared to that found in Europeans (<60%) may suggest an evolutionary influence exerted by diseases that occur at higher prevalences in Africa than in Europe.
###end p 68
###begin p 69
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTLA4</italic>
Our finding of strong LD in a study population from West Africa between variants at position +6230 and the SNP located in the promoter region of CTLA4 (-1577) may open new avenues in the search for mechanisms which mediate the immunomodulatory effect of the +6230 variant.
###end p 69
###begin p 70
###xml 38 50 <span type="species:ncbi:9606">participants</span>
The authors are grateful to the study participants. They thank hospital staff and recruitment teams as well as field workers and nurses and, furthermore, Lincoln Gankpala, Emmanuel Abbeyquaye and Gerd Ruge for technical assistance.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
A molecular perspective of CTLA-4 function.
###end article-title 72
###begin article-title 73
Molecular basis of T cell inactivation by CTLA-4.
###end article-title 73
###begin article-title 74
The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.
###end article-title 74
###begin article-title 75
Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.
###end article-title 75
###begin article-title 76
CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function.
###end article-title 76
###begin article-title 77
Reversal of the TCR stop signal by CTLA-4.
###end article-title 77
###begin article-title 78
CTLA-4-Ig regulates tryptophan catabolism in vivo.
###end article-title 78
###begin article-title 79
CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment.
###end article-title 79
###begin article-title 80
Cytotoxic T-lymphocyte antigen-4 inhibits GATA-3 but not T-bet mRNA expression during T helper cell differentiation.
###end article-title 80
###begin article-title 81
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
###end article-title 81
###begin article-title 82
Allelic variant in CTLA4 alters T cell phosphorylation patterns.
###end article-title 82
###begin article-title 83
Immunology of tuberculosis.
###end article-title 83
###begin article-title 84
Haplotype tagging efficiency in worldwide populations in CTLA4 gene.
###end article-title 84
###begin article-title 85
###xml 19 24 <span type="species:ncbi:9606">human</span>
No associations of human pulmonary tuberculosis with Sp110 variants.
###end article-title 85
###begin article-title 86
CTLA-4 blockade enhances the immune response induced by mycobacterial infection but does not lead to increased protection.
###end article-title 86
###begin article-title 87
Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load.
###end article-title 87
###begin article-title 88
Pulmonary tuberculosis: CT and pathologic correlation.
###end article-title 88
###begin article-title 89
###xml 74 77 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals.
###end article-title 89
###begin article-title 90
###xml 56 73 <span type="species:ncbi:10407">hepatitis B virus</span>
Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.
###end article-title 90
###begin article-title 91
Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis.
###end article-title 91
###begin p 92
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 92
###begin p 93
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was funded by the German Ministry for Education and Research through the National Genome Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 93

